An LC-MS/MS method for determination of tenofovir (TFV) in human plasma following tenofovir alafenamide (TAF) administration: Development, validation, cross-validation, and use of formic acid as plasma TFV stabilizer
Deqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, Sophia R. Majeed, Polina German, Brian P. Kearney, Yuwen Zhao, Yuan‐Shek Chen, Lili Ma, Tianyi zhang
Topics & Concepts
Tenofovir alafenamideTenofovirFormic acidProdrugChemistryPharmacologyActive metaboliteMetaboliteDosingHuman immunodeficiency virus (HIV)ChromatographyMedicinePharmacokineticsBiochemistryAntiretroviral therapyVirologyViral loadHIV/AIDS drug development and treatmentHIV Research and TreatmentBlood groups and transfusion